analogous

Documents about analogous

• Modeling Trinity Analogous to Scientific Philosophy#699760PhilArchive
• Is the Brain Analogous to a Quantum Measuring Apparatus?#92354PhilArchive
• Strategically Analogous Mechanisms#1011100arXiv (All)
• Individual and collective memory consolidation: Analogous processes on different levels#753451PhilArchive
• Biological Quantum-Analogous Cognition (BQAC) Consciousness as Adaptive Possibility Management#204223PhilArchive
• Transitioning Regulatory Kinds: Why Gender Transition Isn’t Analogous to ‘Race Transition’#78851PhilArchive
• Analogous motion illusion in audition and vision#633028Bielefeld Pub
• Persistent extensions and analogous bars: data-induced relations between persistence barcodes#215675Ora Oxford University Research
• A Tissue Microenvironment Analogous to Certain Tumor Microenvironments Facilitates HIV Persistence#243500bioRxiv / medRxiv
• Alteration of fresh MIMAS MOX and (U, Ce)O2 analogous materials in simplified cementitious water#176763HAL (France)
• The Future of the Universe Must Be Finite: A Logical Argument Analogous to the Kalam Cosmological Argument#728995PhilArchive
• Discovery and consolidation of analogous reward structure supports generalization in humans#486089PsyArXiv
• Azide-analogous organophosphorus chemistry: RNP2 as a ligand and P-2 source#492696Bielefeld Pub
• Investigating How Users Perceive Interface Differences and Similarities Across Analogous Graphical User Interfaces#178091HAL (France)
• Discovery and consolidation of analogous reward structure supports generalization in humans#423354OSF
• 7 U.S.C. § 398 — Purchase and testing of serums or analogous products; dissemination of test results#562234US Code (LII)
• Using analogous sectors to build good practice resources in regulation of urban faecal sludge emptying and transport.#781385NCBI PubMed Central
• 7 U.S.C. § 394a — Overtime of employees working at establishments which prepare virus, serum, toxin, and analogous products#562230US Code (LII)
• Acoustic Schwarzschild-like black hole and analogous Hawking radiation in Einstein-bumblebee gravity#1455962arXiv (All)
• In Vitro and In Silico Evaluation of the Anti-Infective Potential of EF24-Analogous Curcuminoids: Antiprotozoal Activity and HIV-1 Ribonuclease H Inhibition#1219258HAL (France)
• R-CHOP and Alemtuzumab in Patients With Chronic Lymphocytic Leukemia#1111509ClinicalTrials.gov
• Ley de delitos económicos 21.595: Aproximaciones a la determinación de la pena#1210791DIALNET OAI Articles
• Recombination Rates for $5f^N$ Uranium Ions Using the Analogous $4f^4$ Nd III as a Guideline and Their Effect on Kilonova Nebular SpectraAn Exploration of Recombination of Uranium with application to Kilonovae Spectra#617606arXiv (OAI Expanded)
• Recombination Rates for $5f^N$ Uranium Ions Using the Analogous $4f^4$ Nd III as a Guideline and Their Effect on Kilonova Nebular SpectraAn Exploration of Recombination of Uranium with application to Kilonovae Spectra#618106arXiv (All)
• 9 CFR Part 101 — Definitions#504897Code of Federal Regulations (eCFR)
• 9 CFR Part 115 — Inspections#504909Code of Federal Regulations (eCFR)
• 9 CFR Part 113 — Standard Requirements#504907Code of Federal Regulations (eCFR)
• 9 CFR Part 112 — Packaging and Labeling#504906Code of Federal Regulations (eCFR)
• 9 CFR Part 116 — Records and Reports#504910Code of Federal Regulations (eCFR)
• 9 CFR Part 122 — Organisms and Vectors#504914Code of Federal Regulations (eCFR)
• 9 CFR Part 124 — Patent Term Restoration#504916Code of Federal Regulations (eCFR)
• 9 CFR Part 102 — Licenses for Biological Products#504898Code of Federal Regulations (eCFR)
• 9 CFR Part 104 — Permits for Biological Products#504900Code of Federal Regulations (eCFR)
• 9 CFR Part 117 — Animals at Licensed Establishments#504911Code of Federal Regulations (eCFR)
• 9 CFR Part 118 — Detention; Seizure and Condemnation#504912Code of Federal Regulations (eCFR)
• 9 CFR Part 108 — Facility Requirements for Licensed Establishments#504904Code of Federal Regulations (eCFR)
• 9 CFR Part 114 — Production Requirements for Biological Products#504908Code of Federal Regulations (eCFR)
• 9 CFR Part 109 — Sterilization and Pasteurization at Licensed Establishments#504905Code of Federal Regulations (eCFR)
• 9 CFR Part 105 — Suspension, Revocation, or Termination of Biological Licenses or Permits#504901Code of Federal Regulations (eCFR)
• 9 CFR Part 121 — Possession, Use, and Transfer of Select Agents and Toxins#504913Code of Federal Regulations (eCFR)
• 9 CFR Part 107 — Exemptions from Preparation Pursuant to an Unsuspended and Unrevoked License#504903Code of Federal Regulations (eCFR)
• 9 CFR Part 103 — Experimental Production, Distribution, and Evaluation of Biological Products Prior to Licensing#504899Code of Federal Regulations (eCFR)
• 9 CFR Part 123 — Rules of Practice Governing Proceedings Under the Virus-Serum-Toxin Act#504915Code of Federal Regulations (eCFR)
• 9 CFR Part 106 — Exemption for Biological Products Used in Department Programs or Under Department Control or Supervision#504902Code of Federal Regulations (eCFR)
• 599253 Alberta Ltd. v British Columbia#1492991CanLII
• Wells v Manitoba (Human Rights Commission)#638471CanLII
• Canada (Public Service Alliance) v. Canada#638340CanLII